APLS
Price
$17.43
Change
-$0.97 (-5.27%)
Updated
Jun 27 closing price
Capitalization
2.19B
44 days until earnings call
EYPT
Price
$9.64
Change
-$0.73 (-7.04%)
Updated
Jun 27 closing price
Capitalization
664.03M
32 days until earnings call
Interact to see
Advertisement

APLS vs EYPT

Header iconAPLS vs EYPT Comparison
Open Charts APLS vs EYPTBanner chart's image
Apellis Pharmaceuticals
Price$17.43
Change-$0.97 (-5.27%)
Volume$3.83M
Capitalization2.19B
EyePoint Pharmaceuticals
Price$9.64
Change-$0.73 (-7.04%)
Volume$1.83M
Capitalization664.03M
APLS vs EYPT Comparison Chart in %
Loading...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLS vs. EYPT commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and EYPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (APLS: $17.43 vs. EYPT: $9.65)
Brand notoriety: APLS and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 130% vs. EYPT: 190%
Market capitalization -- APLS: $2.19B vs. EYPT: $664.03M
APLS [@Biotechnology] is valued at $2.19B. EYPT’s [@Biotechnology] market capitalization is $664.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 3 TA indicator(s) are bullish while EYPT’s TA Score has 6 bullish TA indicator(s).

  • APLS’s TA Score: 3 bullish, 6 bearish.
  • EYPT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than APLS.

Price Growth

APLS (@Biotechnology) experienced а -1.47% price change this week, while EYPT (@Biotechnology) price change was +14.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

APLS is expected to report earnings on Aug 11, 2025.

EYPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLS($2.19B) has a higher market cap than EYPT($664M). EYPT YTD gains are higher at: 29.530 vs. APLS (-45.378). EYPT has higher annual earnings (EBITDA): -144.55M vs. APLS (-176.08M). APLS has more cash in the bank: 358M vs. EYPT (318M). EYPT has less debt than APLS: EYPT (24.1M) vs APLS (470M). APLS has higher revenues than EYPT: APLS (776M) vs EYPT (56M).
APLSEYPTAPLS / EYPT
Capitalization2.19B664M330%
EBITDA-176.08M-144.55M122%
Gain YTD-45.37829.530-154%
P/E RatioN/AN/A-
Revenue776M56M1,386%
Total Cash358M318M113%
Total Debt470M24.1M1,950%
FUNDAMENTALS RATINGS
APLS vs EYPT: Fundamental Ratings
APLS
EYPT
OUTLOOK RATING
1..100
5977
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
6535
P/E GROWTH RATING
1..100
10017
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EYPT's Valuation (61) in the Pharmaceuticals Major industry is in the same range as APLS (70) in the Medical Distributors industry. This means that EYPT’s stock grew similarly to APLS’s over the last 12 months.

EYPT's Profit vs Risk Rating (93) in the Pharmaceuticals Major industry is in the same range as APLS (100) in the Medical Distributors industry. This means that EYPT’s stock grew similarly to APLS’s over the last 12 months.

EYPT's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as APLS (98) in the Medical Distributors industry. This means that EYPT’s stock grew similarly to APLS’s over the last 12 months.

EYPT's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as APLS (65) in the Medical Distributors industry. This means that EYPT’s stock grew similarly to APLS’s over the last 12 months.

EYPT's P/E Growth Rating (17) in the Pharmaceuticals Major industry is significantly better than the same rating for APLS (100) in the Medical Distributors industry. This means that EYPT’s stock grew significantly faster than APLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLSEYPT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DODWX15.750.13
+0.83%
Dodge & Cox Global Stock I
AALGX28.940.15
+0.52%
Thrivent Global Stock A
REMCX16.80N/A
N/A
Russell Inv Emerging Markets C
FLRAX41.45N/A
N/A
Nuveen Large Cap Select A
FRRSX15.25N/A
N/A
Franklin Real Estate Securities C

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with ROIV. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
-5.27%
ROIV - APLS
45%
Loosely correlated
-1.81%
BPMC - APLS
44%
Loosely correlated
-0.03%
RARE - APLS
44%
Loosely correlated
-2.46%
EYPT - APLS
44%
Loosely correlated
-6.94%
DNLI - APLS
43%
Loosely correlated
-2.77%
More